Home »
Archive for July, 2012
Archive for July, 2012
Jul. 11 | According to a new study, aspirin and other similar painkillers may help protect against skin cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that skin cancer prevention may be added...
Jul. 11 | In June 2011, the FDA required a new safety label stating that “the use of Actos for more than one year may increase a person’s chance of bladder cancer”. The French Medicines Agency conducted a study of 155,000 patients over four years which revealed...
Jul. 11 | Johnson Research & Development has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose...
Jul. 11 | In recent years, it became clear that people with diabetes face an ominous prospect — a far greater risk of developing Alzheimer’s disease. Biology Professor Chris Li and her colleagues at The City College of New York have discovered that...
Jul. 11 | The U.S. Food and Drug Administration (FDA) approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae...
Jul. 11 | According to a new study, a woman’s weight before and during the pregnancy matters more than glucose level in predicting baby’s size. Being overweight or obese before and during pregnancy is the most reliable predictor of a woman’s risk...
Jul. 5 | Childhood obesity increases likelihood of a cranial disorder that may cause blindness. According to a new Kaiser Permanente study published in The Journal of Pediatrics, children who are overweight or obese — particularly older, non-Hispanic white...
Jul. 5 | The U.S. Food and Drug Administration (FDA) approved Levemir® (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes. It is being marketed by Novo Nordisk, a world leader in diabetes care. With the expansion...
Jul. 5 | GlaxoSmithKline (GSK) was fined with $3 billion by US authorities over charges that it marketed drugs for unauthorized uses, held back safety data, and cheated the government’s Medicaid program. In a long standing case that officials said bared...